Latest Period
n/a
Security Snapshot
Renalytix plc - Ordinary shares, nominal value 0.0025 per share Institutional Ownership
CUSIP: G7489R108
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2022
Institutions Reporting
Shares (Excl. Options)
Price
- Type / Class
- Equity / Ordinary shares, nominal value 0.0025 per share
- Shares outstanding
- 328,915,843
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share is tracked under CUSIP G7489R108.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 2 to 0 between Q1 2022 and Q2 2022.
- Reported value moved from $622,000 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP G7489R108?
CUSIP G7489R108 identifies G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G7489R108:
Institutional Holders of Renalytix plc - Ordinary shares, nominal value 0.0025 per share across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q2 | 0 | $0 | -$622,000 | 0 | |
| 2022 Q1 | 175,206 | $622,000 | -$401,000 | $3.54 | 2 |
| 2021 Q4 | 222,931 | $1,872,000 | -$3,386 | $8.40 | 3 |
| 2021 Q3 | 223,334 | $2,183,000 | -$188,252 | $9.78 | 3 |
| 2021 Q2 | 242,611 | $3,620,000 | -$1,478,238 | $14.92 | 3 |
| 2021 Q1 | 341,675 | $4,431,000 | -$308,296 | $12.97 | 2 |
| 2020 Q4 | 365,446 | $2,435,000 | -$266,332 | $6.66 | 2 |
| 2020 Q3 | 409,311 | $2,246,000 | -$1,181,473 | $5.49 | 3 |
| 2020 Q2 | 630,301 | $4,172,000 | +$689,922 | $6.55 | 3 |
| 2020 Q1 | 526,573 | $1,482,000 | +$167,772 | $2.73 | 3 |
| 2019 Q4 | 463,756 | $2,148,000 | +$712,033 | $4.82 | 3 |
| 2019 Q3 | 313,019 | $943,000 | +$101,003 | $3.01 | 2 |
| 2019 Q2 | 278,519 | $984,000 | +$789,294 | $3.48 | 2 |
| 2019 Q1 | 62,000 | $88,000 | +$88,000 | $1.42 | 1 |